Patient selection criteria. GB, gallbladder; CA 19-9, carbohydrate... | Download Scientific Diagram
Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
Ovarian tumor markers: What to draw and when | MDedge ObGyn
Clinical Value of Serum CEA, CA 19-9, CA 242 and AFP in Diagnosis of Gastrointestinal Tract Cancers - SciAlert Responsive Version
The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer-a report of two cases. | Semantic Scholar
Patients with normal‑range CA19‑9 levels represent a distinct subgroup of pancreatic cancer patients
Usefulness of CA 19–9 for pancreatic cancer screening in patients with new-onset diabetes - ScienceDirect
Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice | Science
What Is CA 19-9 Tumor Marker Blood Test and its Normal Range I Pancreatic Cancer - YouTube
CA 19-9 level in different T stages, grades, depth of invasion, and in... | Download Scientific Diagram
PDF) Pancreatic Cancer with Normal CA 19-9 and Lewis Antigen Negative-Case Report | Journal of Pharmacy and Pharmacology - Academia.edu
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma | PLOS ONE
CA 19-9: handle with care
Clinical Significance of Tumour Markers | Semantic Scholar
Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports
Southwest Journal of Pulmonary, Critical Care and Sleep - Pulmonary - Elevated Tumor Markers In Coccidioidomycosis of the Female Genital Tract
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice | Science
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect
CA 19-9: Reference Range, Interpretation, Collection and Panels
Clinical analysis of four serum tumor markers in 458 patients with ova | CMAR
